197 related articles for article (PubMed ID: 27918208)
1. Investigational hemagglutinin-targeted influenza virus inhibitors.
Zeng LY; Yang J; Liu S
Expert Opin Investig Drugs; 2017 Jan; 26(1):63-73. PubMed ID: 27918208
[TBL] [Abstract][Full Text] [Related]
2. An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.
Holthausen DJ; Lee SH; Kumar VT; Bouvier NM; Krammer F; Ellebedy AH; Wrammert J; Lowen AC; George S; Pillai MR; Jacob J
Immunity; 2017 Apr; 46(4):587-595. PubMed ID: 28423338
[TBL] [Abstract][Full Text] [Related]
3. The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase.
Xie Y; Gong J; Li M; Fang H; Xu W
Curr Med Chem; 2011; 18(7):1050-66. PubMed ID: 21254972
[TBL] [Abstract][Full Text] [Related]
4. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
[TBL] [Abstract][Full Text] [Related]
5. Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.
Zhang Q; Liang T; Nandakumar KS; Liu S
Expert Opin Pharmacother; 2021 Apr; 22(6):715-728. PubMed ID: 33327812
[No Abstract] [Full Text] [Related]
6. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
[TBL] [Abstract][Full Text] [Related]
7. Investigational antiviral therapies for the treatment of influenza.
Yang J; Huang Y; Liu S
Expert Opin Investig Drugs; 2019 May; 28(5):481-488. PubMed ID: 31018720
[TBL] [Abstract][Full Text] [Related]
8. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
[TBL] [Abstract][Full Text] [Related]
9. Novel strategies for prevention and treatment of influenza.
Kandel R; Hartshorn KL
Expert Opin Ther Targets; 2005 Feb; 9(1):1-22. PubMed ID: 15757479
[TBL] [Abstract][Full Text] [Related]
10. A new in vitro hemagglutinin inhibitor screening system based on a single-vesicle fusion assay.
Lee H; Jin W; Jeong BC; Suh JW
Sci Rep; 2016 Jul; 6():30642. PubMed ID: 27469068
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapies on the horizon for influenza.
Naesens L; Stevaert A; Vanderlinden E
Curr Opin Pharmacol; 2016 Oct; 30():106-115. PubMed ID: 27570127
[TBL] [Abstract][Full Text] [Related]
12. Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.
Matsubara T; Onishi A; Yamaguchi D; Sato T
Bioorg Med Chem; 2016 Mar; 24(5):1106-14. PubMed ID: 26833245
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
14. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
15. Influenza virus resistance to antiviral therapy.
van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
[TBL] [Abstract][Full Text] [Related]
16. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
[TBL] [Abstract][Full Text] [Related]
17. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828).
Xie Y; Song W; Xiao W; Gu C; Xu W
Expert Opin Ther Pat; 2013 Nov; 23(11):1517-24. PubMed ID: 23967861
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry.
Nasser ZH; Swaminathan K; Müller P; Downard KM
Antiviral Res; 2013 Nov; 100(2):399-406. PubMed ID: 24012882
[TBL] [Abstract][Full Text] [Related]
20. [Antiviral Drugs Targeting Influenza Virus Surface Proteins: A Computational Structural Biology Approach].
Igarashi M
Yakugaku Zasshi; 2015; 135(9):1015-21. PubMed ID: 26329546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
